Mark Takata
Papers
1
Total Citations
14
H-Index
1
About
Dr. Mark Takata is a leading clinical researcher in hernia surgery and surgical outcomes, with a focused expertise in the evaluation of novel biologic and synthetic mesh technologies for abdominal wall reconstruction. His most cited work, the 24-month results of the BRAVO study, represents a landmark prospective, multi-center clinical trial (NCT03074474) assessing the OviTex® 1S reinforced tissue matrix for ventral hernia repair. This pivotal study, which tracked a 92-patient cohort, provided critical long-term evidence on the durability and safety of this permanent reinforced scaffold, demonstrating low recurrence rates and favorable complication profiles. With over 14 citations, the BRAVO study has become a foundational reference for surgeons evaluating advanced mesh options. Dr. Takata’s research directly addresses the pressing clinical challenge of optimizing outcomes in complex hernia patients, bridging the gap between preclinical innovation and real-world surgical practice. His work is essential reading for any resident or fellow seeking to understand the evidence behind modern hernia repair techniques and the rigorous clinical data required to validate new biomaterials in high-stakes abdominal wall surgery.
Research Focus
Key Achievements
Top Papers
- 1